catalog number :
MBS9205733
products full name :
PLA2G7 Antibody (Center)
products short name :
[PLA2G7]
products name syn :
[Platelet-activating factor acetylhydrolase; PAF acetylhydrolase; 1-alkyl-2-acetylglycerophosphocholine esterase; 2-acetyl-1-alkylglycerophosphocholine esterase; Group-VIIA phospholipase A2; gVIIA-PLA2; LDL-associated phospholipase A2; LDL-PLA(2); PAF 2-acylhydrolase; PLA2G7; PAFAH]
other names :
[platelet-activating factor acetylhydrolase; Platelet-activating factor acetylhydrolase; platelet-activating factor acetylhydrolase; phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma); 1-alkyl-2-acetylglycerophosphocholine esterase; 2-acetyl-1-alkylglycerophosphocholine esterase; Group-VIIA phospholipase A2; gVIIA-PLA2; LDL-associated phospholipase A2; LDL-PLA(2); PAF 2-acylhydrolase]
products gene name :
[PLA2G7]
other gene names :
[PLA2G7; PLA2G7; PAFAD; PAFAH; LP-PLA2; LDL-PLA2; PAFAH; PAF acetylhydrolase; gVIIA-PLA2; LDL-PLA(2)]
uniprot entry name :
PAFA_HUMAN
sequence positions :
[200-228]
specificity :
This PLA2G7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 200-228 amino acids from the Central region of human PLA2G7.
purity :
Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
form :
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
storage stability :
Maintain refrigerated at 2-8 degree C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
tested application :
IHC-P, FC, WB, ELISA
app notes :
WB~~1:1000. IHC-P~~1:10~50. FC~~1:25
image3 heading :
Testing Data
image4 heading :
Western Blot
image4 description :
All lanes : Anti-PLA2G7 Antibody (Center) at 1:2000 dilution Lane 1: human liver lysate Lane 2: human lung lysate Lane 3: human spleen lysate Lane 4: human plasma lysate Lysates/proteins at 20 ?g per lane. Secondary Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/10000 dilution. Predicted band size : 50 kDa Blocking/Dilution buffer: 5% NFDM/TBST.
image5 heading :
Western Blot
image5 description :
Western blot analysis of PLA2G7 Antibody (Center) (Cat. #MBS9205733) in HL-60 cell line lysates (35ug/lane). PLA2G7 (arrow) was detected using the purified Pab.
other info1 :
Function: Modulates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2 ester bond to yield the biolocially inactive lyso-PAF. Has a specificity for substrates with a short residue at the sn-2 position. It is inactive against long-chain phospholipids.
other info2 :
Cellular Location: Secreted, extracellular space. Tissue Location: Plasma.
products categories :
Cardiovascular; Immunology
products description :
The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency.
products references :
Fan, P., et al. Hum. Reprod. 25(5):1288-1294(2010). Paik, J.K., et al. Clin. Chim. Acta 411 (7-8), 486-493 (2010). Meng, X., et al. Psychiatry Res 175 (1-2), 186-187 (2010). McGeachie, M., et al. Circulation 120(24):2448-2454(2009). Cojocaru, I.M., et al. Rom J Intern Med 47(1):61-65(2009)
ncbi acc num :
NP_001161829.1
ncbi gb acc num :
NM_001168357.1
ncbi summary :
The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency. Two transcript variants encoding the same protein have been found for this gene.[provided by RefSeq, Dec 2009]
uniprot summary :
PLA2G7: Modulates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2 ester bond to yield the biologically inactive lyso-PAF. Has a specificity for substrates with a short residue at the sn-2 position. It is inactive against long-chain phospholipids. Defects in PLA2G7 are the cause of platelet-activating factor acetylhydrolase deficiency (PAFAD). An enzymatic deficiency that results in exacerbated bodily response to inflammatory agents. Asthmatic individuals affected by this condition may manifest severe respiratory symptoms. Defects in PLA2G7 are a cause of susceptibility to asthma (ASTHMA). The most common chronic disease affecting children and young adults. It is a complex genetic disorder with a heterogeneous phenotype, largely attributed to the interactions among many genes and between these genes and the environment. It is characterized by recurrent attacks of paroxysmal dyspnea, with weezing due to spasmodic contraction of the bronchi. PLA2G7 variants can be a risk factor for the development of asthma and PLA2G7 may act as a modifier gene that modulates the severity of this disease. Defects in PLA2G7 are a cause of susceptibility to atopic hypersensitivity (ATOPY). A condition characterized by predisposition to develop hypersensitivity reactions. Atopic individuals can develop eczema, allergic rhinitis and allergic asthma. Belongs to the AB hydrolase superfamily. Lipase family. Protein type: Secreted, signal peptide; Hydrolase; EC 3.1.1.47; Secreted; Lipid Metabolism - ether lipid. Chromosomal Location of Human Ortholog: 6p21.2-p12. Cellular Component: cytoplasm; extracellular region. Molecular Function: calcium-independent phospholipase A2 activity; phospholipid binding; 1-alkyl-2-acetylglycerophosphocholine esterase activity. Biological Process: cellular protein metabolic process; lipid catabolic process; positive regulation of inflammatory response. Disease: Asthma, Susceptibility To; Ige Responsiveness, Atopic; Platelet-activating Factor Acetylhydrolase Deficiency